Radhakrishnan Archana, Grande David, Ross Michelle, Mitra Nandita, Bekelman Justin, Stillson Christian, Pollack Craig Evan
From the Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD (AR, CEP); the Division of General Internal Medicine, Hospital of the University of Pennsylvania Philadelphia (DG, CS); the Department of Biostatistics and Epidemiology, Hospital of the University of Pennsylvania (MR, NM); the Department of Radiation Oncology, Hospital of the University of Pennsylvania (JB); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore (CEP).
J Am Board Fam Med. 2017 May-Jun;30(3):298-307. doi: 10.3122/jabfm.2017.03.160359.
The role of primary care providers (PCPs) in decision making around cancer care remains largely unknown. We evaluated how frequently men with localized prostate cancer report receiving help from their PCP about their treatment, and whether those men who do are less likely to receive definitive treatment.
We mailed surveys to men newly diagnosed with localized prostate cancer between 2012 and 2014 in the greater Philadelphia region. Participants were asked whether their PCP helped decide how to treat their cancer. The outcome was receipt of definitive treatment (either radical prostatectomy or radiotherapy).
A total of 2386 men responded (adjusted response rate, 51.1%). Among these men, 38.2% reported receiving help from their PCP regarding choosing a treatment, and 79.6% received definitive treatment. In adjusted analyses, non-Hispanic black men (odds ratio, 1.76; 95% confidence interval, 1.37-2.27) were more likely than non-Hispanic white men to report receiving help from their PCP. However, men who did receive help were not more likely to forgo definitive treatment overall ( = .58) or in the subgroups of men who may be least likely to benefit from definitive treatment.
Though a substantial proportion of men reported receiving help from their PCP about prostate cancer treatment, these discussions were not associated with different treatment patterns. Further effort is needed to determine how to optimize the role of PCPs in supporting patients to make preference-sensitive cancer decisions.
基层医疗服务提供者(PCP)在癌症治疗决策中的作用在很大程度上仍不明确。我们评估了局限性前列腺癌男性患者报告从其基层医疗服务提供者处获得治疗帮助的频率,以及那些获得帮助的男性患者接受确定性治疗的可能性是否较低。
我们向2012年至2014年在大费城地区新诊断为局限性前列腺癌的男性邮寄了调查问卷。参与者被问及他们的基层医疗服务提供者是否帮助决定如何治疗他们的癌症。结果是接受确定性治疗(根治性前列腺切除术或放射治疗)。
共有2386名男性做出回应(调整后的回应率为51.1%)。在这些男性中,38.2%报告从其基层医疗服务提供者处获得了关于选择治疗方法的帮助,79.6%接受了确定性治疗。在调整分析中,非西班牙裔黑人男性(优势比,1.76;95%置信区间,1.37 - 2.27)比非西班牙裔白人男性更有可能报告从其基层医疗服务提供者处获得帮助。然而,总体而言,获得帮助的男性放弃确定性治疗的可能性并未增加(P = 0.58),在可能最不可能从确定性治疗中受益的男性亚组中也是如此。
尽管相当一部分男性报告从其基层医疗服务提供者处获得了关于前列腺癌治疗的帮助,但这些讨论与不同的治疗模式无关。需要进一步努力确定如何优化基层医疗服务提供者在支持患者做出偏好敏感的癌症决策方面的作用。